Endo recalls mislabeled drug lot

Endo USA is voluntarily recalling one lot of clonazepam because of mislabeled strength information, the FDA said July 17. 

Advertisement

Some 60-count cartons of clonazepam orally disintegrating 0.25 milligram tablets might be incorrectly labeled as 0.125 milligram tablets. Blister strips inside the package reflect the correct strength, the agency said. 

Endo is advising customers to discontinue use of the product, which could cause significant sedation, ataxia or respiratory depression if the wrong dosage is consumed. 

Zero adverse events have been reported.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.